ANIP - ANI Pharmaceuticals, Inc.
76.89 0.00 (0.00%)
After hours: 4:42PM EDT
| Previous Close | 77.05 |
| Open | 76.84 |
| Bid | 73.30 x 900 |
| Ask | 76.67 x 1800 |
| Day's Range | 76.10 - 77.21 |
| 52 Week Range | 36.92 - 78.35 |
| Volume | 101,950 |
| Avg. Volume | 129,487 |
| Market Cap | 925.517M |
| Beta (3Y Monthly) | 1.79 |
| PE Ratio (TTM) | 66.98 |
| EPS (TTM) | 1.15 |
| Earnings Date | Nov 1, 2017 - Nov 6, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 87.00 |
- PR Newswire•4 days ago
ANI Pharmaceuticals Announces Approval of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5ml
BAUDETTE, Minn. , June 20, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has received FDA approval of its Prior Approval Supplement for Vancomycin ...
- PR Newswire•6 days ago
ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc.
BAUDETTE, Minn., June 18, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (ANIP) today announced that it has acquired a pipeline of seven development stage generic products from Coeptis Pharmaceuticals, Inc. for $2.3 million dollars in cash and up to $12.0 million in additional development and commercial milestones. As part of the agreement, ANI will pay a portion of gross profit generated from one of the injectable products to the commercial manufacturing partner. Included in the purchase price, ANI is also acquiring raw materials (API), manufacturing and packaging components, and reference drug valued at approximately $1.5M combined.
- PR Newswire•12 days ago
ANI Pharmaceuticals to Present at Raymond James Life Sciences and MedTech Conference
BAUDETTE, Minn., June 12, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (ANIP) will present on June 18, 2019 at Raymond James' Life Sciences and MedTech Conference in New York City. Arthur Przybyl, President and CEO and Stephen Carey, Vice President and CFO, will present at 8:00 AM ET on Tuesday, June 18, 2019. ANI Pharmaceuticals, Inc. (the "Company" or "ANI") is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals.
- Simply Wall St.•24 days ago
Is ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Trading At A 48% Discount?
In this article we are going to estimate the intrinsic value of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) by taking the...
- Zacks•last month
What Makes ANI (ANIP) a New Buy Stock
ANI (ANIP) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Thomson Reuters StreetEvents•last month
Edited Transcript of ANIP earnings conference call or presentation 9-May-19 2:30pm GMT
Q1 2019 ANI Pharmaceuticals Inc Earnings Call
Motley Fool•last monthANI Pharmaceuticals Inc (ANIP) Q1 2019 Earnings Call Transcript
ANIP earnings call for the period ending March 31, 2019.
- Insider Monkey•2 months ago
Did Hedge Funds Drop The Ball On ANI Pharmaceuticals Inc (ANIP) ?
Is ANI Pharmaceuticals Inc (NASDAQ:ANIP) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after adjusting for known risk […]
- Associated Press•2 months ago
ANI: 1Q Earnings Snapshot
On a per-share basis, the Baudette, Minnesota-based company said it had net income of 4 cents. Earnings, adjusted for non-recurring costs, came to $1.30 per share. The drugmaker posted revenue of $52.9 ...
- PR Newswire•2 months ago
ANI Pharmaceuticals Reports First Quarter 2019 Results and Reaffirms Guidance
BAUDETTE, Minn. , May 9, 2019 /PRNewswire/ -- For the first quarter 2019: Net revenues of $52.9 million , an increase of 14% versus 2018 GAAP net income of $0.4 million and diluted GAAP earnings per share ...
- PR Newswire•2 months ago
ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2019 Financial Results
BAUDETTE, Minn. , May 2, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its first quarter 2019 financial results on Thursday, May 9, 2019 ...
- Zacks•2 months ago
ANI Pharmaceuticals (ANIP) Dips More Than Broader Markets: What You Should Know
ANI Pharmaceuticals (ANIP) closed at $70.24 in the latest trading session, marking a -1.04% move from the prior day.
- Zacks•2 months ago
The Zacks Analyst Blog Highlights: Bed Bath & Beyond, ANI, DXP, Foot Locker and ACI
The Zacks Analyst Blog Highlights: Bed Bath & Beyond, ANI, DXP, Foot Locker and ACI
- Zacks•2 months ago
What's in Store for ANI Pharmaceuticals (ANIP) Q1 Earnings?
ANI Pharmaceuticals (ANIP) will provide updates on product launches, when it releases first-quarter 2019 results.
- Zacks•2 months ago
American Economy Hits the Gas: 5 Top Gainers
The U.S. economy grew 3.2% in the first quarter of 2019, primarily on two typically volatile components - inventories and trade.
- Simply Wall St.•2 months ago
If You Had Bought ANI Pharmaceuticals (NASDAQ:ANIP) Shares Five Years Ago You'd Have Made 115%
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company that is really flourishing, you can make more than 100%. For instance, the price of ANI Pharmaceuticals...
- Zacks•2 months ago
Medicines Company (MDCO) Q1 Loss Narrows, Inclisiran in Focus
The Medicines Company (MDCO) suffers narrower-than-expected loss in Q1. The company progresses well with its sole pipeline candidate, inclisiran.
- Zacks•2 months ago
Alexion (ALXN) Q1 Earnings Beat Estimates, Guidance Raised
Alexion (ALXN) beats earnings and sales estimates in the first quarter of 2019 and raises guidance for the year.
- Zacks•2 months ago
Zacks.com featured expert Kevin Matras highlights: Advanced Emissions Solutions, Verint Systems, Great Lakes Dredge & Dock, ANI Pharmaceuticals and ACI Worldwide
Zacks.com featured expert Kevin Matras highlights: Advanced Emissions Solutions, Verint Systems, Great Lakes Dredge & Dock, ANI Pharmaceuticals and ACI Worldwide
- Zacks•2 months ago
5 Stocks With Recent Price Strength to Enhance Your Returns
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
- Zacks•2 months ago
ANI Pharmaceuticals (ANIP) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, ANI Pharmaceuticals (ANIP) closed at $68.88, marking a -0.17% move from the previous day.
- Zacks•2 months ago
Ultragenyx's (RARE) UX007 Gets Fast Track Status by FDA
Ultragenyx???s (RARE) UX007 receives Fast Track designation and Rare Pediatric Disease designation by the FDA for the treatment of long-chain fatty acid oxidation disorders.
- Zacks•2 months ago
QIAGEN Drives Molecular Diagnostics Suite With New Test Kit
QIAGEN (QGEN) introduces the FDA approved companion diagnostic test to help in guiding therapy in any cancer identification.
- Zacks•2 months ago
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?
Is (ANIP) Outperforming Other Medical Stocks This Year?
